These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 8091682)

  • 21. Anti-hepatits B core antigen testing, viral markers, and occult hepatitis B virus infection in Pakistani blood donors: implications for transfusion practice.
    Bhatti FA; Ullah Z; Salamat N; Ayub M; Ghani E
    Transfusion; 2007 Jan; 47(1):74-9. PubMed ID: 17207233
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influence of the administration of human annexin V on in vitro binding of small hepatitis B surface antigen to human and to rat hepatocytes and on in vitro hepatitis B virus infection.
    De Meyer S; Gong ZJ; Hertogs K; Depla E; van Pelt JF; Roskams T; Maertens G; Yap SH
    J Viral Hepat; 2000 Mar; 7(2):104-14. PubMed ID: 10760040
    [TBL] [Abstract][Full Text] [Related]  

  • 23. C-reactive protein and annexin A5 bind to distinct sites of negatively charged phospholipids present in oxidized low-density lipoprotein.
    van Tits L; de Graaf J; Toenhake H; van Heerde W; Stalenhoef A
    Arterioscler Thromb Vasc Biol; 2005 Apr; 25(4):717-22. PubMed ID: 15692104
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Kinetics of HBV DNA and HBsAg in acute hepatitis B patients with and without coinfection by other hepatitis viruses.
    Chulanov VP; Shipulin GA; Schaefer S; Gerlich WH
    J Med Virol; 2003 Mar; 69(3):313-23. PubMed ID: 12526040
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A chemical lipid modification of recombinant preS antigen to study the mechanism of HBV attachment to the host cell.
    Chen B; Lian M; Xu S; Luo M; Zheng X
    J Biotechnol; 2008 Oct; 137(1-4):8-13. PubMed ID: 18675858
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Coexistence of hepatitis B surface antigen (HBsAg) and heterologous subtype-specific antibodies to HBsAg among patients with chronic hepatitis B virus infection.
    Zhang JM; Xu Y; Wang XY; Yin YK; Wu XH; Weng XH; Lu M
    Clin Infect Dis; 2007 May; 44(9):1161-9. PubMed ID: 17407033
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence and significance of hepatitis B virus (HBV) pre-S mutants in serum and liver at different replicative stages of chronic HBV infection.
    Fan YF; Lu CC; Chen WC; Yao WJ; Wang HC; Chang TT; Lei HY; Shiau AL; Su IJ
    Hepatology; 2001 Jan; 33(1):277-86. PubMed ID: 11124846
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sequence analysis of pre-S/surface and pre-core/core promoter genes of hepatitis B virus in chronic hepatitis C patients with occult HBV infection.
    Kao JH; Chen PJ; Lai MY; Chen DS
    J Med Virol; 2002 Oct; 68(2):216-20. PubMed ID: 12210410
    [TBL] [Abstract][Full Text] [Related]  

  • 29. What is the role of serology for the study of chronic hepatitis B virus infection in the age of molecular biology?
    Galli C; Orlandini E; Penzo L; Badiale R; Caltran G; Valverde S; Gessoni G
    J Med Virol; 2008 Jun; 80(6):974-9. PubMed ID: 18428144
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular characterization of a variant virus that caused de novo hepatitis B without elevation of hepatitis B surface antigen after chemotherapy with rituximab.
    Miyagawa M; Minami M; Fujii K; Sendo R; Mori K; Shimizu D; Nakajima T; Yasui K; Itoh Y; Taniwaki M; Okanoue T; Yoshikawa T
    J Med Virol; 2008 Dec; 80(12):2069-78. PubMed ID: 19040281
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Formation of two-dimensional arrays of annexin V on phosphatidylserine-containing liposomes.
    Pigault C; Follenius-Wund A; Schmutz M; Freyssinet JM; Brisson A
    J Mol Biol; 1994 Feb; 236(1):199-208. PubMed ID: 8107105
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Proteome responses to stable hepatitis B virus transfection and following interferon alpha treatment in human liver cell line HepG2.
    Wang J; Jiang D; Zhang H; Lv S; Rao H; Fei R; Wei L
    Proteomics; 2009 Mar; 9(6):1672-82. PubMed ID: 19242931
    [TBL] [Abstract][Full Text] [Related]  

  • 33. RNA interference inhibits hepatitis B virus gene expression and replication in HepG2-N10 cells.
    Ren JL; Pan JS; Cheng T; Dong J; Lu YP; Huang SJ; Shi HX; Wang L; Lian YM
    Chin J Dig Dis; 2006; 7(4):230-6. PubMed ID: 17054586
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rectification to the article "Involvement of phosphatidylserine and non-phospholipid components of the hepatitis B virus envelope in human annexin V binding and in HBV infection in vitro".
    Yap PS
    J Hepatol; 2000 Sep; 33(3):515. PubMed ID: 11020013
    [No Abstract]   [Full Text] [Related]  

  • 35. The ability of Hepatitis B surface antigen DNA vaccine to elicit cell-mediated immune responses, but not antibody responses, was affected by the deglysosylation of S antigen.
    Xing Y; Huang Z; Lin Y; Li J; Chou TH; Lu S; Wang S
    Vaccine; 2008 Sep; 26(40):5145-52. PubMed ID: 18462847
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence of low-level hepatitis B viremia in patients with HBV surface antigen-negative hepatocellular carcinoma with and without hepatitis C virus infection in Japan: analysis by COBAS TaqMan real-time PCR.
    Toyoda H; Kumada T; Kiriyama S; Sone Y; Tanikawa M; Hisanaga Y; Kanamori A
    Intervirology; 2007; 50(4):241-4. PubMed ID: 17446712
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anti-HBV agents. Part 2: synthesis and in vitro anti-hepatitis B virus activities of alisol A derivatives.
    Zhang Q; Jiang ZY; Luo J; Liu JF; Ma YB; Guo RH; Zhang XM; Zhou J; Chen JJ
    Bioorg Med Chem Lett; 2009 Apr; 19(8):2148-53. PubMed ID: 19289281
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Chronic hepatitis B virus infection and the methylation status of p16INK4A promoter].
    Zhu R; Li BZ; Ling YQ; Zhang HP; Li H; Liu Y; Hu XQ; Zhu HG
    Zhonghua Zhong Liu Za Zhi; 2007 Mar; 29(3):166-70. PubMed ID: 17649629
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Occult hepatitis B virus infection: implications in transfusion.
    Allain JP
    Vox Sang; 2004 Feb; 86(2):83-91. PubMed ID: 15023176
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hepatitis B virus genotypes and hepatitis B surface antigen mutations in family contacts of hepatitis B virus infected patients with occult hepatitis B virus infection.
    Kumar GT; Kazim SN; Kumar M; Hissar S; Chauhan R; Basir SF; Sarin SK
    J Gastroenterol Hepatol; 2009 Apr; 24(4):588-98. PubMed ID: 19207682
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.